Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Oxford_BioMedica> ?p ?o. }
Showing items 1 to 44 of
44
with 100 items per page.
- Oxford_BioMedica abstract "Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. It was established in 1995 as a spin out from Oxford University. The lead product is TroVax, a therapeutic cancer vaccine for multiple solid cancers, which is in Phase III development incollaboration with Sanofi-Aventis. TroVax failed in a key kidney cancer test in 2008 which caused a dramatic drop in Oxford BioMedica's share priceThe Company’s advanced development pipeline includes treatments for cancer, Parkinson's disease and retinopathy. The company's early stage development pipeline includes preclinical candidates for Stargardt disease, motor neuron disease, spinal muscular atrophy and AIDS.".
- Oxford_BioMedica foundingYear "1995".
- Oxford_BioMedica industry Pharma.
- Oxford_BioMedica numberOfEmployees "72".
- Oxford_BioMedica revenue "1500000.0".
- Oxford_BioMedica wikiPageExternalLink www.oxfordbiomedica.co.uk.
- Oxford_BioMedica wikiPageID "22613261".
- Oxford_BioMedica wikiPageRevisionID "603907086".
- Oxford_BioMedica companyName "Oxford BioMedica plc".
- Oxford_BioMedica companyType "Public company".
- Oxford_BioMedica foundation "1995".
- Oxford_BioMedica hasPhotoCollection Oxford_BioMedica.
- Oxford_BioMedica industry Pharma.
- Oxford_BioMedica numEmployees "72".
- Oxford_BioMedica revenue "1500000".
- Oxford_BioMedica website www.oxfordbiomedica.co.uk.
- Oxford_BioMedica subject Category:Biopharmaceuticals.
- Oxford_BioMedica subject Category:Pharmaceutical_companies_of_the_United_Kingdom.
- Oxford_BioMedica type Abstraction100002137.
- Oxford_BioMedica type Company108058098.
- Oxford_BioMedica type Group100031264.
- Oxford_BioMedica type Institution108053576.
- Oxford_BioMedica type Organization108008335.
- Oxford_BioMedica type SocialGroup107950920.
- Oxford_BioMedica type YagoLegalActor.
- Oxford_BioMedica type YagoLegalActorGeo.
- Oxford_BioMedica type YagoPermanentlyLocatedEntity.
- Oxford_BioMedica type Agent.
- Oxford_BioMedica type Company.
- Oxford_BioMedica type Organisation.
- Oxford_BioMedica type Organization.
- Oxford_BioMedica type Agent.
- Oxford_BioMedica type SocialPerson.
- Oxford_BioMedica type Thing.
- Oxford_BioMedica comment "Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. It was established in 1995 as a spin out from Oxford University. The lead product is TroVax, a therapeutic cancer vaccine for multiple solid cancers, which is in Phase III development incollaboration with Sanofi-Aventis.".
- Oxford_BioMedica label "Oxford BioMedica".
- Oxford_BioMedica sameAs m.05zs_3c.
- Oxford_BioMedica sameAs Q17019665.
- Oxford_BioMedica sameAs Q17019665.
- Oxford_BioMedica sameAs Oxford_BioMedica.
- Oxford_BioMedica wasDerivedFrom Oxford_BioMedica?oldid=603907086.
- Oxford_BioMedica homepage www.oxfordbiomedica.co.uk.
- Oxford_BioMedica isPrimaryTopicOf Oxford_BioMedica.
- Oxford_BioMedica name "Oxford BioMedica plc".